.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Business PracticeSee All >

Business
Development
Legal
Policy
Practice
Regulatory

About
Contact
Advisory Board
Do Not Sell My Information
Terms & Conditions
Privacy Policy

Stakeholders Summit: Provider Education on Biosimilars

EP. 1: Pfizer's Citizen Petition on Biosimilar Communications

January 10th 2019

EP. 2: Combating Misinformation and Misconceptions About Biosimilars

January 10th 2019

EP. 3: Targeted Education for Biosimilar Stakeholders

January 10th 2019

EP. 4: US Versus EU Education on Biosimilars

January 10th 2019

EP. 5: The FDA's Approach to Biosimilar Education

January 10th 2019

EP. 6: Biosimilarity, Manufacturing Changes, and Comparability

January 10th 2019

EP. 7: Clinicians' Understanding of Manufacturing Changes

January 10th 2019

EP. 8: The Extrapolation of Indications

January 10th 2019

EP. 9: Selecting the Most Sensitive Population for Confirmatory Trials

January 10th 2019

EP. 10: Immunogenicity and Biosimilars

January 10th 2019